2014 [26] |
Combination of a few simple objects |
Skin and fat |
None |
A model easy to accomplish but oversimplified |
2017 [21] |
Threshold segmentation from contrast-enhanced MRI data |
Skin, vessel, fat and fibroglandular tissue |
None |
Accurate representation of the breast anatomy but suffers from large computational burden and huge time consumption, only 50 patients’ data were acquired |
2017 [27] |
Combination of a few simple objects |
Background soft tissue |
A circular target that had absorption properties of hemoglobin |
A 2D model easy to accomplish but oversimplified, the optical parameters are inaccurate |
2018 [22] |
Load the initial PA pressure from X-ray breast image after processing |
Background soft tissue visualized by X-ray images |
Benign and malignant tumors segmented from X-ray images |
Large database available, easy to accomplish, while the real PA images are significantly different from the simulated ones, the X-ray images can’t give enough contrast between malignant and benign tumors as well as between vessels and other background tissues |
2018 [28] |
Combination of a few simple objects |
Glandular tissue and vessels |
None |
A 2D model easy to accomplish but oversimplified |
2019 [23] |
Application of the second phantom |
Skin, vessel, fat and fibroglandular tissue |
Tumors acquired from mice studies (imaged with fluorescent imaging system) |
Tumor models derived from mice studies; no distinction between tumor types |
2020 [24] |
Segmentation of the digital mammography (DM) dataset based on deep learning |
Skin, fat and fibroglandular tissue |
Segmented from DM dataset |
Large database available, high efficiency but only in 2D, does not include vessel structures which are crucial for PA imaging |
2021 [25] |
Reconstruct the 3D breast model through a series of 2D US B-scan slices, then perform segmentation |
Skin, fat and fibroglandular tissue |
Segmented manually from US images |
Accurate representation of the breast anatomy but does not include vessel structures, suffers from large time consumption, no distinction between tumor types |